Prophylactic strategies to control chikungunya virus infection

被引：11

作者：

Hucke, Friederike I. L. ^{[1
]}

Bestehorn-Willmann, Malena ^{[1
]}

Bugert, Joachim J. ^{[1
]}

机构：

[1] Bundeswehr Inst Microbiol, Neuherbergstr 11, D-80937 Munich, Germany

来源：

VIRUS GENES | 2021年 / 57卷 / 02期

关键词：

CHIKV epidemiology; Antiviral design; Antiviral testing; Vaccines; Monoclonal antibodies; AEDES-ALBOPICTUS; MONOCLONAL-ANTIBODIES; GENETIC-DETERMINANTS; NONHUMAN-PRIMATES; RISK-FACTORS; VACCINE; REPLICATION; DENGUE; DISEASE; ALPHAVIRUS;

D O I：

10.1007/s11262-020-01820-x

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Chikungunya virus (CHIKV) is a (re)emerging arbovirus and the causative agent of chikungunya fever. In recent years, CHIKV was responsible for a series of outbreaks, some of which had serious economic and public health impacts in the affected regions. So far, no CHIKV-specific antiviral therapy or vaccine has been approved. This review gives a brief summary on CHIKV epidemiology, spread, infection and diagnosis. It furthermore deals with the strategies against emerging diseases, drug development and the possibilities of testing antivirals against CHIKV in vitro and in vivo. With our review, we hope to provide the latest information on CHIKV, disease manifestation, as well as on the current state of CHIKV vaccine development and post-exposure therapy.

引用

页码：133 / 150

页数：18

共 147 条

[21] Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques [J].

Broeckel, Rebecca ;

Fox, Julie M. ;

Haese, Nicole ;

Kreklywich, Craig N. ;

Sukulpovi-Petty, Soila ;

Legasse, Alfred ;

Smith, Patricia P. ;

Denton, Michael ;

Corvey, Carsten ;

Krishnan, Shiv ;

Colgin, Lois M. A. ;

Ducore, Rebecca M. ;

Lewis, Anne D. ;

Axthelm, Michael K. ;

Mandron, Marie ;

Cortez, Pierre ;

Rothblatt, Jonathan ;

Rao, Ercole ;

Focken, Ingo ;

Carter, Kara ;

Sapparapau, Gopal ;

Crowe, James E., Jr. ;

Diamond, Michael S. ;

Streblow, Daniel N. .

PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (06)

[22] The Alphavirus Exit Pathway: What We Know and What We Wish We Knew [J].

Brown, Rebecca S. ;

Wan, Judy J. ;

Kielian, Margaret .

VIRUSES-BASEL, 2018, 10 (02)

[23] Antivirals in medical biodefense [J].

Bugert, J. J. ;

Hucke, F. ;

Zanetta, P. ;

Bassetto, M. ;

Brancale, A. .

VIRUS GENES, 2020, 56 (02) :150-167

[24]

Callaway Ewen, 2020, Nature, DOI 10.1038/d41586-020-00180-8

[25]

Callaway E, 2017, NATURE, V542, P15, DOI 10.1038/542015a

[26] Dengue and Other Common Causes of Acute Febrile Illness in Asia: An Active Surveillance Study in Children [J].

Capeding, Maria Rosario ;

Chua, Mary Noreen ;

Hadinegoro, Sri Rezeki ;

Hussain, Ismail I. H. M. ;

Nallusamy, Revathy ;

Pitisuttithum, Punnee ;

Rusmil, Kusnandi ;

Thisyakorn, Usa ;

Thomas, Stephen J. ;

Ngoc Huu Tran ;

Wirawan, Dewa Nyoman ;

Yoon, In-Kyu ;

Bouckenooghe, Alain ;

Hutagalung, Yanee ;

Laot, Thelma ;

Wartel, Tram Anh .

PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (07)

[27] Local and regional spread of chikungunya fever in the Americas [J].

Cauchemez, S. ;

Ledrans, M. ;

Poletto, C. ;

Quenel, P. ;

de Valk, H. ;

Colizza, V. ;

Boelle, P. Y. .

EUROSURVEILLANCE, 2014, 19 (28) :15-23

[28] The Range of Neurological Complications in Chikungunya Fever [J].

Cerny, T. ;

Schwarz, M. ;

Schwarz, U. ;

Lemant, J. ;

Gerardin, P. ;

Keller, E. .

NEUROCRITICAL CARE, 2017, 27 (03) :447-457

[29] Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial [J].

Chang, Lee-Jah ;

Dowd, Kimberly A. ;

Mendoza, Floreliz H. ;

Saunders, Jamie G. ;

Sitar, Sandra ;

Plummer, Sarah H. ;

Yamshchikov, Galina ;

Sarwar, Uzma N. ;

Hu, Zonghui ;

Enama, Mary E. ;

Bailer, Robert T. ;

Koup, Richard A. ;

Schwartz, Richard M. ;

Akahata, Wataru ;

Nabel, Gary J. ;

Mascola, John R. ;

Pierson, Theodore C. ;

Graham, Barney S. ;

Ledgerwood, Julie E. .

LANCET, 2014, 384 (9959) :2046-2052

[30] Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus [J].

Clayton, April M. .

JOURNAL OF INFECTIOUS DISEASES, 2016, 214 :S506-S509

← 1 2 3 4 5 6 7 8 9 10 →